These findings suggest that suppressing miR-939-3p or inducing BATF2 expression may represent a new therapeutic strategy for sarcoma treatment, which may provide novel insights for the development of potent therapeutic approaches for sarcoma patients. Here, BATF2 is linked to sarcoma.